This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
NF-kappaB Signaling and Biology: From Bench to Bedside
joint with Ubiquitin Signaling
Organizer(s): Michael Karin and Hao Wu
Date: March 18 - 23, 2012
Location: Whistler Conference Centre, Whistler, BC, Canada
Sponsored by Onyx Pharmaceuticals, Inc.
Summary of Meeting:
The regulation and function of NF-kB have captivated molecular and cellular biologists, as well as immunologists, pathologists and drug developers for many years. Studies of NF-kB and its regulation have taught us many fundamental lessons and principals in basic biological sciences as well as in biomedicine. Although rapidly reaching maturity, with 25 years since its discovery, the NF-kB field remains vibrant and fertile, and never ceases to amaze with new groundbreaking discoveries. The Keystone Symposia meeting on NF-kB Signaling and Biology: From Bench to Bedside will cover the basic biochemistry of NF-kB signaling; how NF-kkB accomplishes its main job as a transcription factor; the roles of the NF-kB system in immunity and inflammation; how NF-kB controls cell death, survival and metabolism; and how all of these functions go awry during disease development – something that we have learned both from studies of genetically altered mice and from studies of human genetic defects and pathology. Finally, this meeting will teach us how we might fix and cure these problems through the pharmacological targeting of the NF-kB system. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Ubiquitin Signaling, which will share a keynote address and three plenary sessions with this meeting.
Scholarship Deadline: November 16 2011
Discounted Abstract Deadline: November 16 2011
Abstract Deadline: December 20 2011
Discounted Registration Deadline: January 18 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Onyx Pharmaceuticals, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.

Millennium Pharmaceuticals, Inc., The Takeda Oncology Company
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
EMBO (European Molecular Biology Organization)
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI098239-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found